CASTAGNA, ANTONELLA
CASTAGNA, ANTONELLA
Facoltà di Medicina e Chirurgia
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study
2016-01-01 Nozza, Silvia; Pignataro, Angela Rosa; Galli, Laura; Svicher, Valentina; Alteri, Claudia; Boeri, Enzo; Ripa, Marco; Castagna, Antonella; Sampaolo, Michela; Clementi, Massimo; Perno, Carlo Federico; Lazzarin, Adriano
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination
2024-01-01 Bottanelli, M.; Messina, E.; Raccagni, A. R.; Moschetta, N.; Clementi, N.; Muccini, C.; Castagna, A.; Nozza, S.
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients
1997-01-01 D'Arminio Monforte, A.; Cinque, P.; Vago, L.; Rocca, A.; Castagna, A.; Gervasoni, C.; Terreni, M. R.; Novati, R.; Gori, A.; Lazzarin, A.; Moroni, M.
A follow-up study in asymptomatic HIV patients
1997-01-01 Fornara, C; Medaglini, S; Cursi, M; Leocani, ANNUNZIATA MARIA LETIZIA; Locatelli, T; Castagna, Antonella; Cinque, P; Lazzarin, A; Comi, G.
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults
2023-01-01 Muccini, C.; Castagna, A.
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
2019-01-01 Spagnuolo, Vincenzo; Galli, Laura; Poli, Andrea; Bigoloni, Alba; Fumagalli, Luca; Gianotti, Nicola; Nozza, Silvia; Ferrari, Davide; Locatelli, Massimo; Lazzarin, Adriano; Castagna, Antonella
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial
2005-01-01 Dragsted, Ub; Gerstoft, J; Youle, M; Fox, Z; Losso, M; Benetucci, J; Jayaweera, Dt; Rieger, A; Bruun, Jn; Castagna, Antonella; Gazzard, B; Walmsley, S; Hill, A; Lundgren, Jd
A RELATIVELY SLOW RISK OF DISEASE PROGRESSION IN HIV-POSITIVE PATIENTS WITH INDOLENT INFECTION HAS BEEN FOUND IN THE ICONA COHORT
2009-01-01 Ammassari, A; Cozzi-Lepri, A; De Luca, A; Girardi, E; Arlotti, M; Torti, C; Ladisa, N; Piano, P; Raise, E; Mussini, C; Castagna, A
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
2014-01-01 Mocroft, A.; Reiss, P.; Rakhmanova, A.; Banhegyi, D.; Phillips, A. N.; De Wit, S.; Ristola, M.; Lundgren, J. D.; Grarup, J.; Kirk, O; Eurosida In, Eurocoord; Castagna, Antonella
A whole-genome association study of major determinants for host control of HIV-1
2007-01-01 Fellay, Jacques; Shianna Kevin, V.; Ge, Dongliang; Colombo, Sara; Ledergerber, Bruno; Weale, Mike; Zhang, Kunlin; Gumbs, Curtis; Castagna, Antonella; Cossarizza, Andrea; Cozzi Lepri, Alessandro; De Luca, Andrea; Easterbrook, Philippa; Francioli, Patrick; Mallal, Simon; Martinez Picado, Javier; Miro Jose, M.; Obel, Niels; Smith Jason, P.; Wyniger, Josiane; Descombes, Patrick; Antonarakis Stylianos, E.; Letvin Norman, L.; McMichael Andrew, J.; Haynes Barton, F.; Telenti, Amalio; Goldstein David, B.
Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort
2018-01-01 Roen, A; Laut, K; Pelchen-Matthews, A; Borodulina, E; Caldeira, L; Clarke, A; Clotet, B; d'Arminio Monforte, A; Fätkenheuer, G; Gatell Artigas, Jm; Karpov, I; Kuznetsova, A; Kyselyova, G; Mozer-Lisewska, I; Mulcahy, F; Ragone, L; Scherrer, A; Uzdaviniene, V; Vandekerckhove, L; Vannappagari, V; Ostergaard, L; Mocroft, A; on behalf of the EuroSIDA, Study; Castagna, A; Lazzarin, A
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir
2006-01-01 Gianotti, Nicola; Galli, Laura; Danise, Anna; Hasson, Hamid; Boeri, Enzo; Lazzarin, Adriano; Castagna, Antonella
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study
2009-01-01 van Luin, Matthijs; Bannister Wendy, P.; Mocroft, Amanda; EuroSIDA Study, Grp; Castagna, A
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort
2017-01-01 Monforte, Antonella D'arminio; Cozzi lepri, Alessandro; Ceccherini silberstein, Francesca; De Luca, Andrea; Caputo, Sergio Lo; Castagna, Antonella; Mussini, Cristina; Cingolani, Antonella; Tavelli, Alessandro; Shanyinde, Milensu; Gori, Andrea; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Puoti, Massimo
Achieving virological control in pan-resistant HIV-1 infection: A case series
2022-01-01 Canetti, D.; Muccini, C.; Spagnuolo, V.; Galli, L.; Poli, A.; Gianotti, N.; Feasi, M.; Castagna, A.
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV
2017-01-01 De Luca, Andrea; Lorenzini, Patrizia; Castagna, Antonella; Puoti, M; Gianotti, N; Castelli, F; Mastroianni, C; Maggiolo, F; Antinori, A; Guaraldi, G; Lichtner, M; D'arminio Monforte, A; on behalf of the ICONA Fdn Study, Grp
All-cause mortality in treated HIV-infected adults with CD4 >= 500/mm(3) compared with the general population: evidence from a large European observational cohort collaboration
2012-01-01 Lewden, Charlotte; Bouteloup, Vincent; De Wit, Stephane; Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Group; Castagna, A
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier
2021-01-01 Oltolini, C.; Piemontese, S.; Ripa, M.; Greco, R.; Nozza, S.; Corti, C.; Peccatori, J.; Scarpellini, P.; Ciceri, F.; Castagna, A.
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment
2007-01-01 Seminari, E; De Bona, A; Gentilini, G; Galli, L; Schira, G; Gianotti, N; UBERTI FOPPA, Caterina; Soldarini, A; Dorigatti, F; Lazzarin, A; Castagna, Antonella
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
2014-01-01 Cozzi Lepri, Alessandro; Antinori, Andrea; Bonora, Stefano; Cingolani, Antonella; Cassola, Giovanni; Angarano, Gioacchino; Vullo, Vincenzo; Mussini, Cristina; Gori, Andrea; Maggiolo, Franco; Castagna, Antonella; Monforte Antonella, D'Arminio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study | 1-gen-2016 | Nozza, Silvia; Pignataro, Angela Rosa; Galli, Laura; Svicher, Valentina; Alteri, Claudia; Boeri, Enzo; Ripa, Marco; Castagna, Antonella; Sampaolo, Michela; Clementi, Massimo; Perno, Carlo Federico; Lazzarin, Adriano | |
| A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination | 1-gen-2024 | Bottanelli, M.; Messina, E.; Raccagni, A. R.; Moschetta, N.; Clementi, N.; Muccini, C.; Castagna, A.; Nozza, S. | |
| A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients | 1-gen-1997 | D'Arminio Monforte, A.; Cinque, P.; Vago, L.; Rocca, A.; Castagna, A.; Gervasoni, C.; Terreni, M. R.; Novati, R.; Gori, A.; Lazzarin, A.; Moroni, M. | |
| A follow-up study in asymptomatic HIV patients | 1-gen-1997 | Fornara, C; Medaglini, S; Cursi, M; Leocani, ANNUNZIATA MARIA LETIZIA; Locatelli, T; Castagna, Antonella; Cinque, P; Lazzarin, A; Comi, G. | |
| A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults | 1-gen-2023 | Muccini, C.; Castagna, A. | |
| A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study | 1-gen-2019 | Spagnuolo, Vincenzo; Galli, Laura; Poli, Andrea; Bigoloni, Alba; Fumagalli, Luca; Gianotti, Nicola; Nozza, Silvia; Ferrari, Davide; Locatelli, Massimo; Lazzarin, Adriano; Castagna, Antonella | |
| A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial | 1-gen-2005 | Dragsted, Ub; Gerstoft, J; Youle, M; Fox, Z; Losso, M; Benetucci, J; Jayaweera, Dt; Rieger, A; Bruun, Jn; Castagna, Antonella; Gazzard, B; Walmsley, S; Hill, A; Lundgren, Jd | |
| A RELATIVELY SLOW RISK OF DISEASE PROGRESSION IN HIV-POSITIVE PATIENTS WITH INDOLENT INFECTION HAS BEEN FOUND IN THE ICONA COHORT | 1-gen-2009 | Ammassari, A; Cozzi-Lepri, A; De Luca, A; Girardi, E; Arlotti, M; Torti, C; Ladisa, N; Piano, P; Raise, E; Mussini, C; Castagna, A | |
| A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe | 1-gen-2014 | Mocroft, A.; Reiss, P.; Rakhmanova, A.; Banhegyi, D.; Phillips, A. N.; De Wit, S.; Ristola, M.; Lundgren, J. D.; Grarup, J.; Kirk, O; Eurosida In, Eurocoord; Castagna, Antonella | |
| A whole-genome association study of major determinants for host control of HIV-1 | 1-gen-2007 | Fellay, Jacques; Shianna Kevin, V.; Ge, Dongliang; Colombo, Sara; Ledergerber, Bruno; Weale, Mike; Zhang, Kunlin; Gumbs, Curtis; Castagna, Antonella; Cossarizza, Andrea; Cozzi Lepri, Alessandro; De Luca, Andrea; Easterbrook, Philippa; Francioli, Patrick; Mallal, Simon; Martinez Picado, Javier; Miro Jose, M.; Obel, Niels; Smith Jason, P.; Wyniger, Josiane; Descombes, Patrick; Antonarakis Stylianos, E.; Letvin Norman, L.; McMichael Andrew, J.; Haynes Barton, F.; Telenti, Amalio; Goldstein David, B. | |
| Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort | 1-gen-2018 | Roen, A; Laut, K; Pelchen-Matthews, A; Borodulina, E; Caldeira, L; Clarke, A; Clotet, B; d'Arminio Monforte, A; Fätkenheuer, G; Gatell Artigas, Jm; Karpov, I; Kuznetsova, A; Kyselyova, G; Mozer-Lisewska, I; Mulcahy, F; Ragone, L; Scherrer, A; Uzdaviniene, V; Vandekerckhove, L; Vannappagari, V; Ostergaard, L; Mocroft, A; on behalf of the EuroSIDA, Study; Castagna, A; Lazzarin, A | |
| Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir | 1-gen-2006 | Gianotti, Nicola; Galli, Laura; Danise, Anna; Hasson, Hamid; Boeri, Enzo; Lazzarin, Adriano; Castagna, Antonella | |
| Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study | 1-gen-2009 | van Luin, Matthijs; Bannister Wendy, P.; Mocroft, Amanda; EuroSIDA Study, Grp; Castagna, A | |
| Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort | 1-gen-2017 | Monforte, Antonella D'arminio; Cozzi lepri, Alessandro; Ceccherini silberstein, Francesca; De Luca, Andrea; Caputo, Sergio Lo; Castagna, Antonella; Mussini, Cristina; Cingolani, Antonella; Tavelli, Alessandro; Shanyinde, Milensu; Gori, Andrea; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Puoti, Massimo | |
| Achieving virological control in pan-resistant HIV-1 infection: A case series | 1-gen-2022 | Canetti, D.; Muccini, C.; Spagnuolo, V.; Galli, L.; Poli, A.; Gianotti, N.; Feasi, M.; Castagna, A. | |
| Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV | 1-gen-2017 | De Luca, Andrea; Lorenzini, Patrizia; Castagna, Antonella; Puoti, M; Gianotti, N; Castelli, F; Mastroianni, C; Maggiolo, F; Antinori, A; Guaraldi, G; Lichtner, M; D'arminio Monforte, A; on behalf of the ICONA Fdn Study, Grp | |
| All-cause mortality in treated HIV-infected adults with CD4 >= 500/mm(3) compared with the general population: evidence from a large European observational cohort collaboration | 1-gen-2012 | Lewden, Charlotte; Bouteloup, Vincent; De Wit, Stephane; Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Group; Castagna, A | |
| Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier | 1-gen-2021 | Oltolini, C.; Piemontese, S.; Ripa, M.; Greco, R.; Nozza, S.; Corti, C.; Peccatori, J.; Scarpellini, P.; Ciceri, F.; Castagna, A. | |
| Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment | 1-gen-2007 | Seminari, E; De Bona, A; Gentilini, G; Galli, L; Schira, G; Gianotti, N; UBERTI FOPPA, Caterina; Soldarini, A; Dorigatti, F; Lazzarin, A; Castagna, Antonella | |
| An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy | 1-gen-2014 | Cozzi Lepri, Alessandro; Antinori, Andrea; Bonora, Stefano; Cingolani, Antonella; Cassola, Giovanni; Angarano, Gioacchino; Vullo, Vincenzo; Mussini, Cristina; Gori, Andrea; Maggiolo, Franco; Castagna, Antonella; Monforte Antonella, D'Arminio |